<?xml version="1.0" encoding="UTF-8"?>
<ref id="R53">
 <label>53.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sanchis-Gomar</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Lavie</surname>
    <given-names>CJ</given-names>
   </name>
   <name>
    <surname>Perez-Quilis</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Henry</surname>
    <given-names>BM</given-names>
   </name>
   <name>
    <surname>Lippi</surname>
    <given-names>G</given-names>
   </name>
  </person-group>
  <article-title>Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019.</article-title>
  <source>Mayo Clin Proc</source>
  <year>2020</year>;
  <volume>95</volume>:
  <fpage>1222</fpage>â€“
  <lpage>30</lpage>.
  <pub-id pub-id-type="pmid">32376099</pub-id>
 </mixed-citation>
</ref>
